GLP-1 / GIP Receptor Agonists
Tirzepatide (Mounjaro®) is a long-acting GIP and GLP-1 receptor agonist peptide designed for once-weekly administration. It is a synthetic peptide with a molecular weight of 4813.45 g/mol and a half-life of approximately 5 days.
- Category
- GLP-1 / GIP Receptor Agonists
- Purity
- ≥99.4%
- Price
- from $137.64
- Availability
- In stock
- Size
- 2.5 mg/0.5 mL
- CAS number
- 2023788-19-2
- Molecular formula
- C₂₂₅H₃₄₈N₄₈O₆₈
- Storage
- 36°F to 46°F (2°C to 8°C)
- Half-life
- 120 hours
About GLP-1 / GIP Receptor Agonists
Mounjaro® (Tirzepatide) Product Name: Tirzepatide (Mounjaro®) Category: GLP-1 / GIP Receptor Agonist Peptide Molecular Formula: C₂₂₅H₃₄₈N₄₈O₆₈ Molecular Weight: 4813.45 g/mol Half-Life: Approximately 5 days Storage Condition: Store refrigerated at 2°C–8°C. Protect from light. Do not freeze. Overview: Tirzepatide is a synthetic peptide compound that functions as a dual GIP (glucose-dependent insulinotropic polypeptide) and GLP-1 (glucagon-like peptide-1) receptor agonist. It is designed to activate two incretin pathways that play important roles in metabolic regulation and scientific research. Product Features: - Dual-action GIP and GLP-1 receptor activity - Long-acting peptide structure suitable for once-weekly administration research models - High-quality peptide compound with identity and purity verification available through analytical testing - Suitable for laboratory and scientific research applications Technical Information: - CAS Number: 2023788-19-2 - Appearance: White to off-white lyophilized powder (when supplied as a research compound) - Formulation: Lyophilized peptide format - Testing: Identity and analytical testing available according to batch documentation Applications & Research Areas: - Peptide science research - Metabolic pathway studies - GLP-1 and GIP receptor research - Pharmaceutical research and development - Biological activity studies SEO Keywords: Tirzepatide peptide, Mounjaro peptide, GLP-1 receptor agonist, GIP receptor agonist, dual incretin peptide, metabolic research peptide, pharmaceutical peptide, peptide laboratory research, tirzepatide compound, advanced peptide research. Disclaimer: For research and laboratory use only where applicable. Not intended for human consumption or medical use unless approved and prescribed by a licensed healthcare professional.
Tirzepatide (Mounjaro®) is a long-acting GIP and GLP-1 receptor agonist peptide designed for once-weekly administration. It is a synthetic peptide with a molecular weight of 4813.45 g/mol and a half-life of approximately 5 days.
Store in a cool, dry environment: 36°F to 46°F (2°C to 8°C).
Related Weight Loss & GLP-1 Peptides
GLP-1 / GIP Receptor Agonists Certificate of Analysis · All research peptides
For laboratory research use only. Not for human consumption.